SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NEXL

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Rose who wrote (1652)3/17/2000 1:49:00 PM
From: Seeker   of 1704
 
From Yahoo Nexl thread:

Nicecharts long-term view of NEXL

by: nicecharts (51/M/Southern California) 3/17/00 12:05 pm
Msg: 12363 of 12380
Some call Nexl the Microsoft of the biotechs, some refer to it as the new Intel of its sector. Whatever you call it, I call it a bargain at ANY price under $15 - 'til March 30.

This company, still largely undiscovered and without analysts or earnings projections, will, in my opinion lead the bios into a new era. Soon, instead of being a company whispered about, it will be on everyones lips - and watch lists - and (most importantly) portfolios.

What we have here is a company destined to be rich. Not with any dot-com fantasies of possible growth, but with solid growth, in a hot sector, with HOT products, support, research and REAL life-saving stories!

Anyone who has followed the prolific links to stem-cell research surely must be impressed with Nexell's potential.

Determining the possibility of breast cancer relapse.

The possibility of reversing diabetes.

Manipulation of stem cells - in essence turning cells into little guerilla-fighters, then cutting them loose to kick cancers ass!

Then there are the stories of many who have participated in the tests and are now cancer-free.

Like I said, this is a company destined to become rich, but this is also a company that we investors can feel proud of owning. We are supporting an industry that may save our child's or grandchild's life. Who's not into that?

Nexel is also surrounded by good company and associates. The list of universities, hospitals and labs is respectable, and its relationship with Baxter surely doesn't hurt.

But where will the price go? A few day ago I read a post at clearstation that predicted that this company could be worth $2,000 to $2,500 in the future. I think that the following scenario is entirely possible:

Nexl moves to $15 by earnings. (less than 2 weeks)

Closes the year 2000 @ $40 - 60.

Doubles to $100 by end of 2001.

Doubles to $200 by end of 2002.

Doubles to $400 by end of 2003.

Doubles to $800 by end of 2004.

and by the end of 2005 it hits $1,600. (after a few splits, of course)

Let's say you pick up a thousand shares today at around 9 1/2 and hold them until 2005.

$9,500 turns into a nice retirement nestegg of 1.6 cool million.

And that's conservative.

One other thing. While you're trundling that wheelbarrow full of cash home, you can do it with a smile on your face and a good conscience. You became rich while saving lives.

nicecharts
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext